Pathogenic Mechanisms and Novel Therapeutic Approaches for Sarcomas
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 30450
Special Issue Editor
Special Issue Information
Dear Colleagues,
It is with great pleasure that we announce the upcoming Special Issue of Biomedicines, centered around “Pathogenic Mechanisms and Novel Therapeutic Approaches for Sarcomas”. We warmly invite your contributions to this Special Issue.
Sarcomas comprise a heterogeneous group of rare and understudied cancers of the connective tissue that disproportionally affect the young. Better insights into disease mechanisms and investigations on novel, targeted therapeutic approaches are urgently required to treat these often-young patients. In this Special Issue, we put the spotlight on recent advances in understanding the pathogenic mechanisms driving sarcomas, and the most promising novel therapeutic avenues that have been investigated through preclinical, translational or clinical research. We particularly welcome contributions on advances on targeted therapies, precision medicine, and pathogenic mechanisms on sarcoma subtypes affecting the young, although contributions on adult sarcomas will also certainly be considered.
Dr. Emmy D.G. Fleuren
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcoma
- pediatric and AYA sarcoma
- targeted therapies
- pathogenic mechanisms
- precision medicine.